Status:
COMPLETED
Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis
Lead Sponsor:
Wake Forest University
Collaborating Sponsors:
Zambon SpA
Conditions:
Chronic Bronchitis
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
This is a randonmized, masked, placebo-controlled parallel group, clinical trial to evaluate the effects of three different doses of N-acetyl L-cysteine (NAC) and placebo on patient safety and on phys...
Eligibility Criteria
Inclusion
- Smokers (past or current,20 pack years) with diagnosis of chronic bronchitis
- expectorate sputum daily
- FEV1 of 40-70%
- understand and fill out questionnaire daily
Exclusion
- other investigational within 30 days
- change in smoking habit within 6 months
- pulmonary diagnosis other that chronic bronchitis
- significant renal, cardiac, hepatic or endocrine diseases
- psychiatric disorder or evidence of alcoholism or drug abuse within year
Key Trial Info
Start Date :
January 1 1997
Trial Type :
INTERVENTIONAL
End Date :
March 1 2000
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00205647
Start Date
January 1 1997
End Date
March 1 2000
Last Update
November 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157